The public sector is by far the largest investor globally in basic research to discover important new drugs and vaccines.
The question going forward is do you trade directors with 100 percent purity but facing a steep learning curve with those that are competent and seasoned board members? I would say until proven guilty, you keep working with those you have.
They are taking a hit now with the expectation of this settlement on market timing.
They have been doing more careful underwriting.
They have had more success than other foreign insurers, because of their history. To win in that market depends on being able to win the regulator game. A high-level government official is going to help.
Unless prosecutors win the cooperation-through whatever means of the people below Buffett and Greenberg, it is unlikely that their reach will extend to them.
Whenever you remove uncertainty, it's a good thing. On the downside, they will still have to deal with private shareholders' suits.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.